Transcranial Sonographic Evaluation of Preterm Neonates Presenting With Seizures and Its Association With IA

NCT ID: NCT07051382

Last Updated: 2025-07-04

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

ACTIVE_NOT_RECRUITING

Total Enrollment

122 participants

Study Classification

OBSERVATIONAL

Study Start Date

2025-03-17

Study Completion Date

2026-02-28

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study aimed to evaluate preterm neonates presenting with seizures using transcranial sonography (cranial ultrasound) to detect intracranial abnormalities.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

To determine the prevalence and types of intracranial abnormalities detected by transcranial sonography in preterm neonates who present with seizures, and to analyze the association between these findings and clinical outcomes.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Intracranial Abscess

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

RETROSPECTIVE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Transcranial Sonographic Examination (Cranial Ultrasound)

No evidence of intracranial abnormalities such as intraventricular hemorrhage, germinal matrix hemorrhage, periventricular leukomalacia, hydrocephalus, or infarction.

Brain structures were assessed to be age-appropriate for gestational development.

Intervention Type DIAGNOSTIC_TEST

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Both genders during neonatal period i.e. up to 28 days of postnatal life.
* Seizures having any birth weight and gestational age.3.6.2

Exclusion Criteria

* Preterm with Congenital spinal anomalies causing seizures such as spina-bifida, scoliosisetc.
* Extra-cranial anomalies causing seizures such as arteriovenous malformation (AVM) or metabolic diseases.
Minimum Eligible Age

1 Week

Maximum Eligible Age

20 Weeks

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Superior University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Muhammad Naveed Babur

Principal Investigator

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Mohmand medical complex hospital

Peshawar, Khyber Pakhtunkhwa, Pakistan

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Pakistan

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

MSAHSW/Batch-Fall23/921

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

AEEG in Pre-term Infants
NCT04008498 COMPLETED NA
Patterns of Neonatal Seizures
NCT06726655 NOT_YET_RECRUITING
Heart Beat Variability in Neonatal Encephalopathy
NCT03179553 ACTIVE_NOT_RECRUITING
Brainstem and Prematurity
NCT02669056 COMPLETED NA